Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Treatment |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
07/03/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Saginaw, MI USA |
 |
07/03/2008 |
 |
 |
 |
Details |
 |
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
 |
Detroit, MI USA |
 |
06/28/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
 |
Grand Rapids, MI USA |
 |
06/28/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Detroit, MI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Royal Oak, MI USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
 |
Kalamazoo, MI USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Detroit, MI USA |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
08/26/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
 |
Grand Rapids, MI USA |
 |
06/04/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Kalamazoo, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Lambertville, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Kalamazoo, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
 |
Detroit, MI USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Detroit, MI USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
04/29/2007 |
 |
 |
 |
Details |
 |
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
 |
Grand Rapids, MI USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
 |
Detroit, MI USA |
 |
04/28/2007 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Detroit, MI USA |
 |
01/23/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
11/05/2006 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Royal Oak, MI USA |
 |
10/12/2006 |
 |
 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Kalamazoo, MI USA |
 |
10/12/2006 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Detroit, MI USA |
 |
10/12/2006 |
 |
 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Grand Rapids, MI USA |
 |
10/12/2006 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Ann Arbor, MI USA |
 |
10/12/2006 |
 |
 |
 |
 |
 |
Details |
 |
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
 |
Royal Oak, MI USA |
 |
10/12/2006 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Lambertville, MI USA |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Kalamazoo, MI USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Grand Rapids, MI USA |
 |
05/30/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
 |
Detroit, MI USA |
 |
05/30/2006 |
 |
 |
 |
Details |
 |
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
 |
Ann Arbor, MI USA |
 |
05/04/2006 |
 |
 |
 |
 |
 |
Details |
 |
Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
Details |
 |
Phase I/II Study of Concurrent Dose Escalation Temodar and Whole Brain Radiation Therapy in Patients with Multiple Brain Metastases.
|
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study Utilizing Focal Radiation in Patients with 1-3 Brain Metastases.
|
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
Details |
 |
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) |
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Detroit, MI USA |
 |
02/03/2006 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas |
 |
Detroit, MI USA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Lansing, MI USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Kalamazoo, MI USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Detroit, MI USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Grand Rapids, MI USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Flint, MI USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Ann Arbor, MI USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Detroit, MI USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
 |
Royal Oak, MI USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Lambertville, MI USA |
 |
11/27/2005 |
 |
 |
 |
Details |
 |
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
 |
Ann Arbor, MI USA |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
 |
Lansing, MI USA |
 |
11/26/2005 |
 |
 |
 |
Details |
 |
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
 |
Detroit, MI USA |
 |
11/26/2005 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
 |
Detroit, MI USA |
 |
11/26/2005 |
 |
 |
 |
Details |
 |
Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
 |
Ann Arbor, MI USA |
 |
11/06/2005 |
 |
 |
 |
 |
 |
Details |
 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
 |
Grand Rapids, MI USA |
 |
11/06/2005 |
 |
 |
 |
Details |
 |
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
 |
Grand Rapids, MI USA |
 |
11/06/2005 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
 |
Kalamazoo, MI USA |
 |
11/06/2005 |
 |
 |
 |